Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kauer

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Blood Cancer Discovery|October 13, 2025
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple MyelomaJoseph Kauer, Niels Weinhold, Marc S Raab
Cancers|April 13, 2024
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic BlastsSamuel J Holzmayer, Joseph Kauer, Jonas Mauermann, et al.
Cellular Immunology|February 5, 2020
Genetic loss of NFAT2 (NFATc1) impairs B cell development of B1 and B2 B cellsMelanie Märklin, Jonas S Heitmann, Joseph Kauer, et al.
Scientific Reports|September 23, 2022
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemiaMaddalena Marconato, Joseph Kauer, Helmut R Salih, et al.
International Journal of Hematology|April 9, 2020
CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantationMelanie Märklin, Ilona Hagelstein, Clemens Hinterleitner, et al.
Biotechnology and Bioengineering|May 14, 2021
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestionSebastian Hörner, Michael Ghosh, Joseph Kauer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 30, 2023
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma PatientsSandra Sauer, Lennart Hieke, Juliane Brandt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 8, 2023
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple MyelomaSandra Sauer, Katharina Kriegsmann, Cathleen Nientiedt, et al.
Leukemia & Lymphoma|June 17, 2020
Fc gamma receptor expression serves as prognostic and diagnostic factor in AMLJonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, et al.
Journal for Immunotherapy of Cancer|January 30, 2025
Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphomaClara Kolbe, Joseph Kauer, Berit Brinkmann, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Blood Cancer Discovery|October 13, 2025
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple MyelomaJoseph Kauer, Niels Weinhold, Marc S Raab
Cancers|April 13, 2024
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic BlastsSamuel J Holzmayer, Joseph Kauer, Jonas Mauermann, et al.
Cellular Immunology|February 5, 2020
Genetic loss of NFAT2 (NFATc1) impairs B cell development of B1 and B2 B cellsMelanie Märklin, Jonas S Heitmann, Joseph Kauer, et al.
Scientific Reports|September 23, 2022
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemiaMaddalena Marconato, Joseph Kauer, Helmut R Salih, et al.
International Journal of Hematology|April 9, 2020
CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantationMelanie Märklin, Ilona Hagelstein, Clemens Hinterleitner, et al.
Biotechnology and Bioengineering|May 14, 2021
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestionSebastian Hörner, Michael Ghosh, Joseph Kauer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 30, 2023
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma PatientsSandra Sauer, Lennart Hieke, Juliane Brandt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 8, 2023
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple MyelomaSandra Sauer, Katharina Kriegsmann, Cathleen Nientiedt, et al.
Leukemia & Lymphoma|June 17, 2020
Fc gamma receptor expression serves as prognostic and diagnostic factor in AMLJonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, et al.
Journal for Immunotherapy of Cancer|January 30, 2025
Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphomaClara Kolbe, Joseph Kauer, Berit Brinkmann, et al.
Pageof 4